Incidence, causative factors and mortality rates of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) in northern Italy: data from the REACT registry-Reference-Cited by-同舟云学术

Incidence, causative factors and mortality rates of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) in northern Italy: data from the REACT registry

Published:2015-12-21 Issue:2 Volume:25 Page:196-203
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidemiol Drug Saf

Author:

Diphoorn Janouk¹²³,Cazzaniga Simone²⁴,Gamba Chiara¹,Schroeder Jan⁵,Citterio Antonella⁶,Rivolta Alma Lisa⁷,Vighi Giuseppe Danilo⁸,Naldi Luigi¹²,

Affiliation:

1. Department of Dermatology; Papa Giovanni XXIII Hospital; Bergamo Italy

2. Centro Studi GISED; Bergamo Italy

3. Faculty of Health, Medicine and Life Sciences; Maastricht University; Maastricht The Netherlands

4. Department of Dermatology; Inselspital University Hospital; Bern Switzerland

5. Allergology and Immunology Unit; Niguarda Ca' Granda Hospital; Milano Italy

6. Burn/Intensive Care Department; Niguarda Ca' Granda Hospital; Milano Italy

7. Regional Center of Pharmacovigilance; Lombardy Region; Milano Italy

8. Quality, Privacy and Clinical Risk Unit; Niguarda Ca' Granda Hospital; Milano Italy

Funder

Agenzia Italiana del Farmaco, Ministero della Salute

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pds.3937/fullpdf

Reference32 articles.

1. A multicenter review of toxic epidermal necrolysis treated in U.S. burn centers at the end of the twentieth century;Palmieri;J Burn Care Rehabil,2002

2. Effects of treatments on the mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis: a retrospective study on patients included in the prospective EuroSCAR study;Schneck;J Am Acad Dermatol,2008

3. Severe adverse cutaneous reactions to drugs;Roujeau;N Engl J Med,1994

4. Stevens-Johnson syndrome and toxic epidermal necrolysis. Ear, nose, and throat description at acute stage and after remission;Bequignon;JAMA Dermatol,2015

5. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis;Roujeau;N Engl J Med,1995

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: Analysis of the Russian Database of Spontaneous Reports;Pharmaceuticals;2024-05-24

2. How to Define and Manage Low-Risk Drug Allergy Labels;The Journal of Allergy and Clinical Immunology: In Practice;2024-05

3. Severe cutaneous adverse reactions;Nature Reviews Disease Primers;2024-04-25

4. Emerging Insights into Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Induced by Immune Checkpoint Inhibitor and Tumor-Targeted Therapy;Journal of Inflammation Research;2024-04

5. Cefazolin as the mainstay for antibiotic prophylaxis in patients with a penicillin allergy in obstetrics and gynecology;American Journal of Obstetrics and Gynecology;2024-03